ATE271854T1 - Acetaminophen-formulierung mit verlängerter freisetzung - Google Patents

Acetaminophen-formulierung mit verlängerter freisetzung

Info

Publication number
ATE271854T1
ATE271854T1 AT99945518T AT99945518T ATE271854T1 AT E271854 T1 ATE271854 T1 AT E271854T1 AT 99945518 T AT99945518 T AT 99945518T AT 99945518 T AT99945518 T AT 99945518T AT E271854 T1 ATE271854 T1 AT E271854T1
Authority
AT
Austria
Prior art keywords
acetaminophen
extended release
dissolution
composition
percent
Prior art date
Application number
AT99945518T
Other languages
English (en)
Inventor
Aloysius O Anaebonam
Emmett Clemente
Robert W Mendes
Original Assignee
Ascent Pediatrics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ascent Pediatrics Inc filed Critical Ascent Pediatrics Inc
Application granted granted Critical
Publication of ATE271854T1 publication Critical patent/ATE271854T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
    • A61K9/1676—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface having a drug-free core with discrete complete coating layer containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core

Landscapes

  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
AT99945518T 1998-09-03 1999-09-03 Acetaminophen-formulierung mit verlängerter freisetzung ATE271854T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/146,261 US6254891B1 (en) 1998-09-03 1998-09-03 Extended release acetaminophen
PCT/US1999/020381 WO2000013670A1 (en) 1998-09-03 1999-09-03 Extended release acetaminophen

Publications (1)

Publication Number Publication Date
ATE271854T1 true ATE271854T1 (de) 2004-08-15

Family

ID=22516565

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99945518T ATE271854T1 (de) 1998-09-03 1999-09-03 Acetaminophen-formulierung mit verlängerter freisetzung

Country Status (9)

Country Link
US (1) US6254891B1 (de)
EP (2) EP1109535B1 (de)
AT (1) ATE271854T1 (de)
AU (2) AU5702799A (de)
CA (1) CA2339942C (de)
DE (1) DE69919003T2 (de)
ES (1) ES2230889T3 (de)
HK (1) HK1034903A1 (de)
WO (2) WO2000013669A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0009522D0 (en) 2000-04-19 2000-06-07 Smithkline Beecham Plc Composition
KR100522239B1 (ko) * 2002-07-16 2005-10-18 주식회사 서울제약 아세트아미노펜을 함유하는 제어방출성의 경구용 제제
AU2003300469A1 (en) * 2002-12-31 2004-07-29 Larry L. Augsburger Methods for making pharmaceutical dosage forms containing active cushioning components
US20040186180A1 (en) * 2003-03-21 2004-09-23 Gelotte Cathy K. Non-steroidal anti-inflammatory drug dosing regimen
WO2005030182A1 (en) * 2003-09-26 2005-04-07 Alza Corporation Controlled release formulations exhibiting an ascending rate of release
NZ586198A (en) * 2003-09-26 2011-12-22 Alza Corp Oros push-stick sustained release dosage forms for controlled delivery of active agents
US20050158382A1 (en) * 2003-09-26 2005-07-21 Evangeline Cruz Controlled release formulations of opioid and nonopioid analgesics
EP1708684A2 (de) 2003-09-26 2006-10-11 Alza Corporation Arzneimittelbeschichtung mit hoher arzneimittelbeladung und verfahren dafür
US20050095299A1 (en) * 2003-10-30 2005-05-05 Wynn David W. Controlled release analgesic suspensions
US20050095300A1 (en) * 2003-10-30 2005-05-05 Wynn David W. Controlled release analgesic suspensions
US8541026B2 (en) * 2004-09-24 2013-09-24 Abbvie Inc. Sustained release formulations of opioid and nonopioid analgesics
US20080057122A1 (en) * 2006-08-31 2008-03-06 Aaipharma Inc. Acetaminophen pharmaceutical compositions
US10272097B2 (en) 2013-12-24 2019-04-30 Virginia Commonwealth University Uses of oxygenated cholesterol sulfates (OCS)
WO2016042570A1 (en) * 2014-09-16 2016-03-24 Suresh Pareek Extended release formulation of acetaminophen
MX2022011765A (es) * 2020-03-26 2022-11-09 Provectus Pharmatech Inc Usos novedosos de xantenos halogenados en oncologia y virologia.

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE58110B1 (en) 1984-10-30 1993-07-14 Elan Corp Plc Controlled release powder and process for its preparation
US4867984A (en) * 1984-11-06 1989-09-19 Nagin K. Patel Drug in bead form and process for preparing same
US4874613A (en) * 1987-03-06 1989-10-17 Baker Cummins Pharmaceuticals, Inc. Taste concealing pharmaceutical dosage unit
US4820522A (en) 1987-07-27 1989-04-11 Mcneilab, Inc. Oral sustained release acetaminophen formulation and process
US5032384A (en) 1989-01-27 1991-07-16 Block Drug Company, Inc. Compositions and method for the treatment of disease
US5133974A (en) * 1989-05-05 1992-07-28 Kv Pharmaceutical Company Extended release pharmaceutical formulations
US5773031A (en) * 1996-02-27 1998-06-30 L. Perrigo Company Acetaminophen sustained-release formulation
US5780055A (en) * 1996-09-06 1998-07-14 University Of Maryland, Baltimore Cushioning beads and tablet comprising the same capable of forming a suspension

Also Published As

Publication number Publication date
HK1034903A1 (en) 2001-11-09
DE69919003T2 (de) 2005-08-04
WO2000013670A1 (en) 2000-03-16
CA2339942C (en) 2007-05-22
WO2000013669A1 (en) 2000-03-16
ES2230889T3 (es) 2005-05-01
US6254891B1 (en) 2001-07-03
EP1493434A1 (de) 2005-01-05
DE69919003D1 (de) 2004-09-02
EP1109535A4 (de) 2002-03-13
AU751180B2 (en) 2002-08-08
EP1109535A1 (de) 2001-06-27
AU5702799A (en) 2000-03-27
EP1109535B1 (de) 2004-07-28
CA2339942A1 (en) 2000-03-16
AU5810499A (en) 2000-03-27

Similar Documents

Publication Publication Date Title
ATE271854T1 (de) Acetaminophen-formulierung mit verlängerter freisetzung
DE69730991D1 (de) Alginsaure enthaltende enterischer ueberzug fuer eine orale zubereitung
AU5802299A (en) Extended release acetaminophen
ATE207743T1 (de) Pharmazeutische präparate zur gezielten behandlung von morbus crohn und colitis ulcerosa
DK13491D0 (da) Anvendelse af et enzymholdigt granulat og fremgangsmaade til fremstilling af et forderstof i tabletform
JP2003524421A (ja) リパーゼ含有組成物およびこれらの使用方法
PT98710A (pt) Processo de preparacao de compostos de indolilo substituidos e de composicoes farmaceuticas que os contem
NO870558D0 (no) Fremgangsmaate for fremstilling av et langsomt frigivende farmasoeytisk preparat.
HK1060045A1 (en) Formulations comprising ibuprofen and diphenhydramine and the use thereof for the treatment of sleepdisturbances
NO973646L (no) Orale doseringsformer inneholdende et <beta>-laktam antibiotikum
GEP20043285B (en) Sustained Release Beadlets Containing Stavudine, Method for Their Production, Pharmaceutical Composition Containing the Same and Use Thereof for Treatment Retroviral Infections
ATE342049T1 (de) Mikroverkapselte und mit gesteurter freigabe kräuter formulierungen
SE454566B (sv) Farmaceutisk komposition innehallande en verksam mengd av vattenlosliga proteinaser som extraherats fran ett vattenlevande djur valt av ordningen euphausiaceae eller slektet mallotus
NO172043C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive n-2,3-butadienyl-triamioalkanderivater
HU9201706D0 (en) Process for the production of oxazole derivatives and medical preparation containing them as active agents
AU5763396A (en) Benzothiazoles and benzoxazoles, as well as drugs containing them, their use and methods of preparing them
HUT50762A (en) Process for production of medical compositions containing as active substance derivatives of pirrol and process for production of the active substance
EP0347932A3 (de) Behandlung von Zuständen, die eine erhöhte Sauerstoffverfügbarkeit im Gewebe von Säugern verlangen
Radden et al. Morphological and histochemical studies of bone repair in the rat
Ihse et al. Pancreatic enzymic activities of commercial pancreatic enzyme preparations incubated in human small intestinal juice
NO841372L (no) Fremgangsmaate for fremstilling av dipyridamol-preparater med ph-uavhengig regulert frigjoering
RU95105249A (ru) Гидрохлорид ng монометил-l-аргинина, способы его получения, способ получения фармацевтического препарата и способ лечения
Niessen et al. Studies on the quality of pancreatic preparations: enzyme content, prospective bioavailability, bile acid pattern, and contamination with purines
SAKAI et al. Seasonal changes in the activity of aminopyrine-N-demethylase, one of drug metabolizing enzymes, in the liver of yellowtail
NO871676D0 (no) Fremgangsmaate for enzymatisk behandling av xantangummi.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties